Gilead Sciences, Inc. 13D and 13G filings for Arcellx, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-12-28 5:06 pm Purchase |
2023-12-28 | 13G | Arcellx, Inc. ACLX |
GILEAD SCIENCES INC GILD |
6,720,803 12.900% |
3,242,542![]() (+93.22%) |
Filing |
2023-02-06 4:05 pm Purchase |
2023-01-26 | 13G | Arcellx, Inc. ACLX |
GILEAD SCIENCES INC GILD |
3,478,261 7.300% |
3,478,261![]() (New Position) |
Filing |